Bolt Bio (BOLT): Total Asset Value of Company
Bolt Biotherapeutics (BOLT) centers in the US develop therapies for solid tumors using antibody-conjugate technology to stimulate an immune response. This chart of the company's price action shows that total assets amount to 57.92. The business relies on the Boltbody system, which transforms malignant cells into targets for the body's defenses, while the laboratory minimizes environmental impact through the strict disposal of biological waste.
Comprehensive metric breakdowns and analytics for boltbio.com (BOLT)
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
All Debt to Shareholders' Equity Ratio Bolt Biotherapeutics|BOLT - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Bolt Biotherapeutics, Inc.|BOLT - Company Aggregate Debts|Debts to Book Capitalization Bolt Biotherapeutics|BOLT - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Bolt Biotherapeutics
Fundamental valuation:BOLT, Bolt Bio
Amidst the restructuring of its immuno-oncology portfolio, Bolt Biotherapeutics (BOLT) requires significant resources to develop new molecular combinations. An assessment of controlled resources, calculated inversely via ROA, demonstrates the total value of assets and liabilities, enabling investors to distinguish organic growth from dangerous over-leverage, which increases the company's financial vulnerability in the face of fierce market competition.
Competitors of Bolt Biotherapeutics (BOLT)
ARGX (argenx.com) - Aggregate Business Assets|Aggregate Company Assets BioNTech BNTX|Total Asset Value of Company Abivax|ADMA Bio (ADMA) - Company Total Assets|Aggregate Asset Value Protagonist Corp (PTGX)|Company Total Assets IMVT (Immunovant, Inc.)|kiniksa.com - Company Total Assets|Aggregate Company Assets Grifols (GRFS)|ADPT: Aggregate Asset Value|CLDX (Celldex) - Aggregate Company Assets|Aurinia Corp (AUPH) - Cumulative Company Assets|BCRX (BioCryst) - Company Total Assets|Company Total Assets veratx.com (VERA)|Dianthus Therapeutics, Inc. (DNTH) - Cumulative Company Assets|Aggregate Asset Value Pharvaris NV (PHVS)|Company Total Assets ABCL|Tourmaline - Company Total Asset Base|PGEN: Aggregate Company Assets|PHAR: Cumulative Company Assets|NKTR (Nektar Therapeutics Inc.) - Aggregate Company Assets|Cumulative Company Assets Upstream Bio, Inc.|ZBIO (Zenas Biopharma, Inc.) - Cumulative Company Assets|Company Total Assets IMNM|Aggregate Company Assets Gossamer Bio, Inc. GOSS|Total Business Assets kalvista.com (KALV)|SEPN: Company Total Assets|Company Assets Pieris Pharma PVLA|SVRA - Company Total Assets|RIGL: Aggregate Company Assets|Aggregate Company Assets ANAB|ATXS (astriatx.com) - Company Assets|Aggregate Company Assets enGene|Aggregate Company Assets RAPT Therapeutics Inc. (RAPT)|Cumulative Company Assets Aerovate Therapeutics Inc|Aggregate Business Assets Aclaris Therapeutics, Inc ACRS|Cumulative Company Assets Kyverna Therapeutics|Aggregate Asset Value tizianalifesciences.com TLSA|CABA - Company Total Assets|VTYX - Aggregate Company Assets|Theratechnologies Inc - Company Total Assets|AVTX (Avalo Therapeutics Inc) - Company Total Asset Base|Aggregate Company Assets ELDN (Eledon Pharmaceuticals)|Company Assets agenusbio.com (AGEN)|Cumulative Company Assets Climb Bio|Aggregate Business Assets Zura Bio Ltd (ZURA)|Company Total Assets aTyr|Aggregate Asset Value Adagene Inc ADAG|IMA (Ikena Oncology, Inc.) - Company Total Assets|STTK: Company Assets|Aggregate Company Assets equilliumbio.com EQ|Connect Biopharma Holdings Limited (CNTB) - Aggregate Asset Value|IMUX (Immunic Therapeutics) - Company Total Assets|Company Total Assets ATRA|IFRX - Aggregate Company Assets|Total Asset Value of Company x4pharma.com (XFOR)|ACET: Company Total Assets|CELU - Company Assets|INmune Bio Corp - Cumulative Company Assets|Barinthus Biotherapeutics Corp (BRNS) - Company Total Assets|KZR - Cumulative Company Assets|sabbiotherapeutics.com (SABS) - Aggregate Business Assets|AKTX: Company Total Assets|Company Total Asset Base Enlivex Therapeutics, Ltd.|Company Total Assets QTTB (Q32 Bio Inc.)|Cumulative Company Assets GOVX (GeoVax Corp)|Aggregate Company Assets EDSA|Company Total Asset Base ibioinc.com IBIO|CARM - Company Total Assets|XTLB: Aggregate Company Assets|Aggregate Company Assets HCWB|APVO (Aptevo Therapeutics Inc.) - Company Assets|Aggregate Company Assets AIM ImmunoTech Inc.|Aggregate Company Assets Aditxt Corp (ADTX)|Cumulative Company Assets GRI Bio|Aggregate Business Assets XRTX (XORTX Therapeutics Inc)|ReShape Lifesciences (HIND) - Aggregate Company Assets|Total Asset Value of Company Revelation Biosciences Corp REVB|Company Total Assets Indaptus Therapeutics (INDP)|SCNI - Aggregate Asset Value|CALI: Company Total Assets|AFMD (Affimed N.V.) - Company Total Assets|ALLK - Aggregate Company Assets|Aggregate Asset Value HOOK|Aggregate Company Assets IGMS (IGM Biosciences, Inc.)|Cumulative Company Assets iteostherapeutics.com (ITOS)|Company Total Assets OCEA (Ocean Biomedical)|TCBP - Company Total Assets|Cumulative Company Assets Third Harmonic Bio, Inc (THRD)